Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponsegromab in heart failure with elevated GDF-15
CTR20230542Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ponsegromab in heart failure (HF), sponsored by Pfizer. Started Mar 2023; status: terminated.
02
Drugs
ponsegromab
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20230542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230542.